** Shares of gene-editing specialist Beam Therapeutics
BEAM.O fall ~9.9% to $18.75
** Company says it plans to reduce headcount by about 100
employees, or about 20% of its current workforce, as part of a
restructuring plan
** Related to the workforce reduction, BEAM expects to incur
one-time cost of about $6.6 mln
** The anticipated cost savings and balance of cash expected
fund operations into 2026 - company
** Including session's moves, stock down ~51% YTD
(Reporting by Christy Santhosh in Bengaluru)
((Christy.Santhosh@thomsonreuters.com))